Observational studyMedicina (Kaunas, Lithuania)2022

Comparison of Efficacy and Safety of Original and Biosimilar Adalimumab in Active Rheumatoid Arthritis in a Real-World National Cohort.

Claudiu Costinel Popescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.